After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Third Harmonic Bio Inc is $230.93M. A total of 0.75 million shares were traded on the day, compared to an average of 852.95K shares.
In the most recent transaction, Conner Edward R. sold 2,117 shares of THRD for 15.00 per share on Nov 08 ’24. After the transaction, the Chief Medical Officer now owns 0 company shares. In a previous transaction on Oct 29 ’24, BVF PARTNERS L P/IL sold 1,000,000 shares at 14.30 per share. THRD shares that See Explanation of Responses owns now total 176,692.
Among the insiders who sold shares, Conner Edward R. disposed of 2,673 shares on Oct 28 ’24 at a per-share price of $15.00. This resulted in the Chief Medical Officer holding 0 shares of THRD after the transaction. In another insider transaction, EDWARD CONNER bought 4,790 shares at $13.15 per share on Oct 28 ’24.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, THRD has a high of $16.94 and a low of $3.18.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. THRD’s latest balance sheet shows that the firm has $128.28M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $5.69M in liabilities at the time. Its Book Value Per Share was $6.36, while its Total Shareholder’s Equity was -$46.71M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for THRD is Buy with a score of 3.40.
